• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ROTALINK PLUS; CATHETER, CORONARY, ATHERECTOMY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ROTALINK PLUS; CATHETER, CORONARY, ATHERECTOMY Back to Search Results
Model Number 3241
Device Problems Fracture (1260); Use of Device Problem (1670); Device Damaged by Another Device (2915); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Perforation (2001); Pericardial Effusion (3271)
Event Date 08/08/2018
Event Type  Injury  
Manufacturer Narrative
Initial reporter phone: (b)(6).
 
Event Description
It was reported that the rotawire broke as well as a perforation and pericardial effusion.A rotational atherectomy treatment procedure was being performed in the marginal branch as well as the circumflex (cx).The cx was reported to be 90% stenosed, tortuous with severe calcification.The marginal branch was treated with a 1.25mm rotablator rotalink plus over a 330cm rotawire.Multiple runs were made for 25 seconds at 180,000 rpm lasting more than five minutes with no effect on the calcification using the pecking method per dfu.The physician advanced a new 330cm rotawire in the cx without any problems and removed the previous rotawire.During removal of the rotawire from the vessel, the spiral of the wire tip became stretched.The wire was removed intact.The same 1.25mm rotablator rotalink plus was then advanced over the new 330cm rotawire in the cx and rotablation was started.It was then noted the new rotawire was broken and the burr had perforated the vessel.The perforation was treated with all interventional techniques, followed by pericardial puncture and monitoring.The fractured portion of the rotawire was unable to be retrieved and remains in the patient's distal cx.No further complications were reported and the patient was reported to be stable post procedure.
 
Event Description
It was reported that the rotawire broke as well as a perforation and pericardial effusion.A rotational atherectomy treatment procedure was being performed in the marginal branch as well as the circumflex (cx).The cx was reported to be 90% stenosed, tortuous with severe calcification.The marginal branch was treated with a 1.25mm rotablator rotalink plus over a 330cm rotawire.Multiple runs were made for 25 seconds at 180,000rpm lasting more than five minutes with no effect on the calcification using the pecking method per dfu.The physician advanced a new 330cm rotawire in the cx without any problems and removed the previous rotawire.During removal of the rotawire from the vessel, the spiral of the wire tip became stretched.The wire was removed intact.The same 1.25mm rotablator rotalink plus was then advanced over the new 330cm rotawire in the cx and rotablation was started.It was then noted the new rotawire was broken and the burr had perforated the vessel.The perforation was treated with all interventional techniques, followed by pericardial puncture and monitoring.The fractured portion of the rotawire was unable to be retrieved and remains in the patients distal cx.No further complications were reported and the patient was reported to be stable post procedure.Returned product consisted of the rotalink burr device.The advancer unit was not returned.The handshake connection, sheath, coil and burr were microscopically and visually examined.The coil is stretched.Microscopic examination of the device revealed that the annulus was damaged and not rounded which is consistent with damage seen with the use of a rotawire.There are numerous sheath kinks.Functional testing was completed with a.009" rotawire.The rotawire was inserted through the burr and advanced through the entire length of the device with no issue.Functional testing was performed by connecting the burr catheter to a test advancer and the advancer was attached to the rotablator control console system.The rotablator system was able to reach optimum speed with no abnormal noise and the burr rotated with no issues.Inspection of the remainder of the device presented no other damage or irregularities.
 
Manufacturer Narrative
(b)(6).
 
Manufacturer Narrative
(b)(6).Correction: conclusion code previously reported as no problem detected 67 has been corrected to adverse event related to procedure 4311.Bsc received anonymized media from the hospital.The media was reviewed by a bsc medical director.The following is a summary of the review: the case begins with diagnostic angiography via the radial approach using an amplatz guiding catheter.Arteriograms demonstrated a tight, but not heavily calcified, stenosis in the mid circumflex (lcx) involving the origin of an obtuse marginal (om) branch.The images demonstrated pci to a bifurcation lesion in the mid circumflex (lcx).After unsuccessful rotational atherectomy (ra) to the obtuse marginal (om) branch, the rotawire was repositioned and an attempt was made to ra to the distal lcx.The rotawire tip separated in the distal lcx.This was also apparently associated with vessel perforation (no evidence of contrast extravasation is seen on the images provided) requiring pericardiocentesis and pericardial drain placement.Bleeding through the perforation was apparently controlled by balloon tamponade.At the end of the procedure diminished flow (timi 2) was seen in the om and no flow (timi 0) was seen in the distal lcx.
 
Event Description
It was reported that the rotawire broke as well as a perforation and pericardial effusion.A rotational atherectomy treatment procedure was being performed in the marginal branch as well as the circumflex (cx).The cx was reported to be 90% stenosed, tortuous with severe calcification.The marginal branch was treated with a 1.25mm rotablator rotalink plus over a 330cm rotawire.Multiple runs were made for 25 seconds at 180,000rpm lasting more than five minutes with no effect on the calcification using the pecking method per dfu.The physician advanced a new 330cm rotawire in the cx without any problems and removed the previous rotawire.During removal of the rotawire from the vessel, the spiral of the wire tip became stretched.The wire was removed intact.The same 1.25mm rotablator rotalink plus was then advanced over the new 330cm rotawire in the cx and rotablation was started.It was then noted the new rotawire was broken and the burr had perforated the vessel.The perforation was treated with all interventional techniques, followed by pericardial puncture and monitoring.The fractured portion of the rotawire was unable to be retrieved and remains in the patients distal cx.No further complications were reported and the patient was reported to be stable post procedure.Returned product consisted of the rotalink burr device.The advancer unit was not returned.The handshake connection, sheath, coil and burr were microscopically and visually examined.The coil is stretched.Microscopic examination of the device revealed that the annulus was damaged and not rounded which is consistent with damage seen with the use of a rotawire.There are numerous sheath kinks.Functional testing was completed with a.009" rotawire.The rotawire was inserted through the burr and advanced through the entire length of the device with no issue.Functional testing was performed by connecting the burr catheter to a test advancer and the advancer was attached to the rotablator control console system.The rotablator system was able to reach optimum speed with no abnormal noise and the burr rotated with no issues.Inspection of the remainder of the device presented no other damage or irregularities.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ROTALINK PLUS
Type of Device
CATHETER, CORONARY, ATHERECTOMY
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
MDR Report Key7844316
MDR Text Key119151102
Report Number2134265-2018-60562
Device Sequence Number1
Product Code MCX
UDI-Device Identifier08714729316411
UDI-Public08714729316411
Combination Product (y/n)N
PMA/PMN Number
P900056
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup,Followup
Report Date 02/25/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date04/14/2020
Device Model Number3241
Device Catalogue Number3241
Device Lot Number0022119880
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer09/04/2018
Initial Date Manufacturer Received 08/09/2018
Initial Date FDA Received09/04/2018
Supplement Dates Manufacturer Received09/14/2018
01/31/2019
Supplement Dates FDA Received10/03/2018
02/25/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age58 YR
-
-